ArticlebioRxiv : the preprint server for biology2023
Tumor Immune Cell Targeting Chimeras (TICTACs) For Targeted Depletion of Macrophage-Associated Checkpoint Receptors.
Mariko Morimoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.